Results and long‐term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: An open study with thirty‐five adult patients
Arthritis & Rheumatism2002Vol. 46(2), pp. 467–474
Citations Over TimeTop 10% of 2002 papers
P. Chérìn, S. Pelletier, Antônio Lúcio Teixeira, Pascal Laforêt, T Généreau, Anne Simon, Thierry Maisonobe, B. Eymard, S. Herson
Abstract
IVIG is an interesting therapy for the treatment of polymyositis, with results showing that the condition of approximately 70% of the patients tested improved. After the discontinuation of the IVIG therapy, the efficacy remained stable in 50% of the patients, with a followup of over 3 years.
Related Papers
- → Severe Perturbations of the Blood T Cell Repertoire in Polymyositis, But Not Dermatomyositis Patients(2001)85 cited
- → Rheumatic manifestations of polymyositis and dermatomyositis(1959)59 cited
- → Azathioprine Therapy in Polymyositis(1973)22 cited
- [Intravenous immunoglobulins in the treatment of polymyositis and dermatomyositis].(2000)
- [Pathogenesis of polymyositis and dermatomyositis].(2012)